Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REFIT: Fecal Transplantation for IBS-D
NCT02154867Phase 2Completed
- Sponsor
- University Hospital of North Norway
- Start
- Dec 2014
- Primary completion
- Oct 2016
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing Fecal Transplantation with Placebo (2 arms). Primary endpoint: IBS Severity Scoring System at 3 months. Started Dec 2014; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02154867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02154867.